Hepatotoxicidad por fármacos o productos naturales en niños
The DOI matches its Crossref record, with a small difference in title or year; 4 of the 4 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“According to Ocete-Hita et al. [9], the incidence of adverse drug reactions in children is 15.1 per 1000 children. This represents 2% of admissions to a pediatric hospital, which is similar to the rate observed for adult patients. Fewer than 8% of these children may present liver involvement, which can range from a slight increase in transaminases to fulminant hepatitis.”
From Metabolomic Analysis of Pediatric Patients with Idiosyncratic Drug-Induced Liver Injury According to the Updated RUCAM (2023) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Danan, G., & Benichou, C. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90101-6 · Cited by 1,481 · cited 2×
“Los días desde que se había ingerido el fármaco hasta que se detecto el aumento de enzimas hepáticas presentaron una media de 17,4 ± 23,64 (2-115) (fig.”
Criteria of drug-induced liver disorders
(1990) · Journal of Hepatology · doi:10.1016/0168-8278(90)90124-a · Cited by 1,106 · cited 2×
“Los días desde que se había ingerido el fármaco hasta que se detecto el aumento de enzimas hepáticas presentaron una media de 17,4 ± 23,64 (2-115) (fig.”
Risk Factors for Idiosyncratic Drug-Induced Liver Injury
Chalasani, N., & Björnsson, E. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.001 · Cited by 347 · cited 2×
“Los días desde que se había ingerido el fármaco hasta que se detecto el aumento de enzimas hepáticas presentaron una media de 17,4 ± 23,64 (2-115) (fig.”
Antibiotic-Induced Liver Toxicity: Mechanisms, Clinical Features and Causality Assessment
Robles, M., Toscano, E., Cotta, J., Isabel Lucena, M., & J. Andrade, R. (2010) · Current Drug Safety · doi:10.2174/157488610791698307 · Cited by 45
Research works printed but not linked: 26
- Ferrajolo, 2010, Drug-induced hepatic injury in children: a case/non-case study of suspected adverse drug reactions in VigiBase, Br J Clin Pharmacol, 70, 721, 10.1111/j.1365-2125.2010.03754.x · DOI · Paper page
- Planchamp, 2009, Active drug monitoring of adverse drug reactions in pediatric emergency department, Arch Pediatr, 16, 106, 10.1016/j.arcped.2008.11.013 · DOI
- Giri, 2010, Hepatotoxicity and hepatic metabolism of available drugs: current problems and possible solutions in preclinical stages, Expert Opin Drug Metab Toxicol, 6, 895, 10.1517/17425251003792521 · DOI
- Gomez-Lechon, 2010, In vitro evaluation of potential hepatotoxicity induced by drugs, Curr Pharm Des, 16, 1963, 10.2174/138161210791208910 · DOI · Paper page
- Murray, 2008, Drug-related hepatotoxicity and acute liver failure, J Pediatr Gastroenterol Nutr, 47, 395, 10.1097/MPG.0b013e3181709464 · DOI · Paper page
- Navarro, 2006, Drug-related hepatotoxicity, N Engl J Med, 354, 731, 10.1056/NEJMra052270 · DOI · Paper page
- Squires, 2006, Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group, J Pediatr, 148, 652, 10.1016/j.jpeds.2005.12.051 · DOI · Paper page
- Lim, 2006, Severe liver injury after initiating therapy with atomoxetine in two children, J Pediatr, 148, 831, 10.1016/j.jpeds.2006.01.035 · DOI
- Mecarelli, 2005, Acute hepatitis associated with lamotrigine and managed with the molecular adsorbents recirculating system (Mars), Epilepsia, 46, 1687, 10.1111/j.1528-1167.2005.00269.x · doi:10.1111/j.1528-1167.2005.00269.x
- Bessmertny, 2001, Antiepileptic hypersensitivity syndrome in children, Ann Pharmacother, 35, 533, 10.1345/aph.10284 · DOI
- Molleston, 2011, Characteristics of idiosyncratic drug-induced liver injury in children: results from the DILIN prospective study, J Pediatr Gastroenterol Nutr, 53, 182, 10.1097/MPG.0b013e31821d6cfd · DOI · Paper page
- Fontana, 2010, Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop, Hepatology, 52, 730, 10.1002/hep.23696 · DOI · Paper page
- Peire, 2002, Drug-induced hepatotoxicity in children. Where we are and where were are going, An Esp Pediatr, 56, 434
- Tujios, 2011, Mechanisms of drug-induced liver injury: from bedside to bench, Nat Rev Gastroenterol Hepatol, 8, 202, 10.1038/nrgastro.2011.22 · DOI · Paper page
- Stine, 2011, Drug-induced liver injury: a summary of recent advances, Expert Opin Drug Metab Toxicol, 7, 875, 10.1517/17425255.2011.577415 · DOI · Paper page
- Maddur, 2011, Idiosyncratic drug-induced liver injury: a clinical update, Curr Gastroenterol Rep, 13, 65, 10.1007/s11894-010-0154-8 · DOI
- Lucena, 2011, Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish Registry: the dilemma of the relationship to autoimmune hepatitis, J Hepatol, 55, 820, 10.1016/j.jhep.2010.12.041 · DOI · Paper page
- Petronijevic, 2011, Drug induced hepatotoxicity: data from the Serbian pharmacovigilance database, Pharmacoepidemiol Drug Saf, 20, 416, 10.1002/pds.2115 · DOI
- Rangnekar, 2011, An update on drug induced liver injury, Minerva Gastroenterol Dietol, 57, 213
- Lammert, 2008, Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals, Hepatology, 47, 2003, 10.1002/hep.22272 · DOI · Paper page
- Garcia-Cortes, 2011, Causality assessment methods in drug induced liver injury: strengths and weaknesses), J Hepatol, 55, 683, 10.1016/j.jhep.2011.02.007 · DOI · Paper page
- Miljkovic, 2011, Consistency between causality assessments obtained with two scales and their agreement with clinical judgments in hepatotoxicity, Pharmacoepidemiol Drug Saf, 20, 272, 10.1002/pds.2081 · DOI · Paper page
- Andrade, 2008, Rechallenge in hepatotoxicity: proof of concept or therapeutic accident, Rev Esp Enferm Dig, 100, 255
- Andrade, 2007, Assessment of drug-induced hepatotoxicity in clinical practice: a challenge for gastroenterologists, World J Gastroenterol, 13, 329, 10.3748/wjg.v13.i3.329 · DOI · Paper page
- Maria, 1997, Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis, Hepatology, 26, 664, 10.1002/hep.510260319 · DOI · Paper page
- Agarwal, 2010, Important elements for the diagnosis of drug-induced liver injury, Clin Gastroenterol Hepatol, 8, 463, 10.1016/j.cgh.2010.02.008 · DOI · Paper page
Cited by
Andújar-Vera, F., Alés-Palmer, M. L., Muñoz-de-Rueda, P., Iglesias-Baena, I., & Ocete-Hita, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713562 · Cited by 10
Metadata
- Authors
- Ocete Hita, E., Martín García, J. A., Giménez Sánchez, F., Flores González, J. C., Abril Molina, A., Salmerón Escobar, J., & Ruiz Extremera, A.
- Venue
- Anales de Pediatría
- Publisher
- Elsevier BV
- Published
- 2013-04
- Volume
- 78
- Issue
- 4
- Pages
- 248-259
- ISSN
- 1695-4033
- Cited by
- 10
- References
- 4
- Language
- es
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 4888 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.